The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon
about
The Rotterdam Study: 2010 objectives and design updateA C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding riskPharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumonPharmacogenetics of anticoagulants.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.The Rotterdam Study: 2012 objectives and design update.The Rotterdam Study: objectives and design update.Functional Characterization of Human CYP2C9 Allelic Variants in COS-7 Cells.Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.Pharmacogenetics of cardiovascular drug therapy.
P2860
Q24653733-D4A18D83-BE21-4281-8520-8C74252773FDQ24817078-A290C685-A8C5-4A6D-9B26-56C5D9633377Q27006860-7D1D59D9-D403-47A9-A4D3-E5EA1E429C9EQ34219746-4C1AFB85-3BA0-4D92-9C95-E251E516F022Q34252907-23EEB00A-0712-4152-BD48-6C5301F527C3Q34746605-236AC3D0-C38E-49BC-A5D2-90A9F05D54A6Q35201574-2D8962A4-7000-45C4-8C52-99011AEA9E3EQ36128893-7C62CA4D-BE75-42A0-A6C6-2598E821D8CEQ36831692-E048A9E1-4B68-4F8C-ABD2-1E7C0B3B532AQ37160370-6EADD1A8-76C4-4E42-851C-BCB789758CBAQ37219846-492BF5D3-AC8F-4F8C-977A-6C9943666807Q37430401-9A3A7591-97A6-4135-A18E-1C2A517F071A
P2860
The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@ast
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@en
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@nl
type
label
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@ast
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@en
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@nl
prefLabel
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@ast
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@en
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@nl
P2093
P3181
P356
P1476
The risk of bleeding complicat ...... acenocoumarol or phenprocoumon
@en
P2093
Arnold G Vulto
Bruno H Ch Stricker
Loes E Visser
Martin van Vliet
Paul H Trienekens
Peter A G M De Smet
Ron H N van Schaik
P3181
P356
10.1160/TH03-12-0741
P407
P577
2004-07-01T00:00:00Z